EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

De novo serine biosynthesis is protective in mitochondrial disease

Christopher B Jackson, Anastasiia Marmyleva, Geoffray Monteuuis, Ryan Awadhpersad, Takayuki Mito, Nicola Zamboni, Takashi Tatsuta, Amy E Vincent, Liya Wang, Nahid A Khan, Thomas Langer, Christopher J Carroll und 1 weitere

Cell Reports · 2025-05 · 44 (5) · 115710

DOI: 10.1016/j.celrep.2025.115710 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025-05. Verfasst von Christopher B Jackson und 12 weiteren Autor:innen. Beteiligte Einrichtung: Research Programs Unit, Stem Cells and Metabolism, University of Helsinki, 00290 Helsinki, Finland; Department of Biochemistry and Developmental Biol…. Hauptthemen laut MEDLINE: Serine, Mitochondrial Diseases. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Jane and Aatos Erkko Fundation, Novartis Foundation for Medical-Biological Research, Swiss National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SerineMitochondrial DiseasesAnimalsPhosphoglycerate DehydrogenaseMuscle, SkeletalMiceMitochondriaOxidative PhosphorylationGlucoseHumansMice, Inbred C57BLMale

Stichwörter der Autor:innen

CP: Metabolismde novo serine synthesismitochondrial diseasemitochondrial integrated stress responsemitochondrial translationtissue specificitytreatment

Substanzen

SerinePhosphoglycerate DehydrogenaseGlucose

Autor:innen und Institutionen

  • Research Programs Unit, Stem Cells and Metabolism, University of Helsinki, 00290 Helsinki, Finland; Department of Biochemistry and Developmental Biology, University of Helsinki, 00290 Helsinki, Finland. Electronic addre…
  • Research Programs Unit, Stem Cells and Metabolism, University of Helsinki, 00290 Helsinki, Finland.
  • Department of Biochemistry and Developmental Biology, University of Helsinki, 00290 Helsinki, Finland.
  • Institute of Molecular Systems Biology, Department of Biology, ETH Zurich, 8093 Zurich, Switzerland.
  • Max Planck Institute for Aging, 50931 Cologne, Germany.
  • Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.

Förderung

  • Jane and Aatos Erkko Fundation
  • Novartis Foundation for Medical-Biological Research
  • Swiss National Science Foundation
  • Research Council of Finland
  • Magnus Ehrnroothin Säätiö
  • Sigrid Juséliuksen Säätiö

Zitieren

APA

Jackson, C. B., Marmyleva, A., Monteuuis, G., Awadhpersad, R., Mito, T., Zamboni, N., Tatsuta, T., Vincent, A. E., Wang, L., Khan, N. A., Langer, T., Carroll, C. J., & Suomalainen, A. (2025). De novo serine biosynthesis is protective in mitochondrial disease. Cell Reports, 44(5), 115710. https://doi.org/10.1016/j.celrep.2025.115710

Vancouver

Jackson CB, Marmyleva A, Monteuuis G, Awadhpersad R, Mito T, Zamboni N, et al. De novo serine biosynthesis is protective in mitochondrial disease. Cell Reports. 2025;44(5):115710. doi:10.1016/j.celrep.2025.115710

BibTeX
@article{Jackson2025,
  author = {Jackson, Christopher B and Marmyleva, Anastasiia and Monteuuis, Geoffray and Awadhpersad, Ryan and Mito, Takayuki and Zamboni, Nicola and Tatsuta, Takashi and Vincent, Amy E and Wang, Liya and Khan, Nahid A and Langer, Thomas and Carroll, Christopher J and Suomalainen, Anu},
  title = {De novo serine biosynthesis is protective in mitochondrial disease},
  journal = {Cell Reports},
  year = {2025},
  volume = {44},
  number = {5},
  pages = {115710},
  doi = {10.1016/j.celrep.2025.115710}
}
Kostenlos starten →